SEC 13F Intelligence

Payden & Rygel / JNJ

Payden & Rygel’s Johnson & Johnson Position

Does Payden & Rygel own Johnson & Johnson (JNJ)? Yes — 61.4K shares worth $15M (+1.16% of its 13F portfolio) as of Q1 2026.

Position Value
$15M
Q1 2026
Shares
61.4K
% of Portfolio
+1.16%
Quarters Held
26
currently held

Position History JNJ

Reported value by quarter
Q1 ’19: $27MQ1 ’19Q2 ’19: $27MQ3 ’19: $14MQ4 ’19: $16MQ1 ’20: $15MQ1 ’20Q2 ’20: $16MQ3 ’20: $24MQ4 ’20: $25MQ1 ’21: $27MQ1 ’21Q2 ’21: $27MQ3 ’21: $28MQ4 ’21: $29MQ1 ’22: $20MQ1 ’22Q2 ’22: $20MQ3 ’22: $19MQ4 ’22: $21MQ1 ’23: $19MQ1 ’23Q2 ’23: $13MQ4 ’23: $12MQ3 ’24: $7MQ4 ’24: $5MQ4 ’24Q1 ’25: $11MQ2 ’25: $10MQ3 ’25: $12MQ4 ’25: $13MQ4 ’25Q1 ’26: $15Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202661.4K$15M+1.16%
Q4 202561.4K$13M+0.88%
Q3 202564.9K$12M+1.00%
Q2 202564.9K$10M+0.82%
Q1 202564.9K$11M+0.92%
Q4 202437.0K$5M+0.46%
Q3 202443.8K$7M+0.55%
Q4 202378.3K$12M+0.85%
Q2 202380.0K$13M+0.94%
Q1 2023123.4K$19M+1.13%
Q4 2022118.0K$21M+1.11%
Q3 2022118.0K$19M+1.13%
Q2 2022115.2K$20M+1.23%
Q1 2022115.2K$20M+1.03%
Q4 2021170.3K$29M+1.35%
Q3 2021170.3K$28M+1.43%
Q2 2021164.0K$27M+1.29%
Q1 2021164.8K$27M+1.26%
Q4 2020161.6K$25M+1.30%
Q3 2020161.6K$24M+1.43%
Q2 2020116.2K$16M+1.04%
Q1 2020116.2K$15M+1.10%
Q4 2019109.3K$16M+1.00%
Q3 2019109.3K$14M+0.96%
Q2 2019192.6K$27M+1.84%
Q1 2019191.5K$27M+1.95%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Payden & Rygel’s full portfolio or all institutional holders of JNJ.